Theravance Biopharma, Inc. Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security
Theravance Biopharma, Inc. (TBPH) reported Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security of $0 for the 12-month period ending 2013-12-31, per its 10-K filed 2015-03-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities · last filed 2015-03-13
- Theravance Biopharma, Inc. repayment of long-term debt, long-term lease obligation, and capital security for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- Theravance Biopharma, Inc. repayment of long-term debt, long-term lease obligation, and capital security for fiscal 2012 was $69.00K.
| Period end | Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security 12 month |
|---|---|
| 2013-12-31 | $0.00 10-K · filed 2015-03-13 |
| 2012-12-31 | $69.00K 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |